Publications by authors named "Xueyong Zhu"

Claim this Profile
V
VH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion.
Rameshwar U Kadam, Jarek Juraszek, Boerries Brandenburg, Divita Garg, Xueyong Zhu

Npj Viruses· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human monoclonal antibodies targeting A35 protect from death caused by mpox.
Raianna F Fantin, Meng Yuan, Seok-Chan Park, Bailey Bozarth, Hallie Cohn, Xueyong Zhu

Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation.
Xueyong Zhu, Ahmed M Khalil, Michael S Piepenbrink, Wenli Yu, Yao Ma

Commun Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift.
Ge Song, Meng Yuan, Hejun Liu, Tazio Capozzola, Ryan N Lin, Xueyong Zhu

Cell Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation.
Xueyong Zhu, Ahmed M Khalil, Michael S Piepenbrink, Wenli Yu, Yao Ma

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins.
Jenna J Guthmiller, Linda Yu-Ling Lan, Lei Li, Yanbin Fu, Sean A Nelson, Xueyong Zhu

Immunity· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
María Ríos Carrasco, Ting-Hui Lin, Xueyong Zhu, Alba Gabarroca García, Elif Uslu

Proc Natl Acad Sci U S A· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of V3 and V3 genes.
Ting-Hui Lin, Chang-Chun David Lee, Monica L Fernández-Quintero, James A Ferguson, Julianna Han, Xueyong Zhu

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, Alesandra J Rodriguez, Weina Sun

Proc Natl Acad Sci U S A· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacy.
Steven W de Taeye, Loïc Faye, Bertrand Morel, Angela I Schriek, Jeffrey C Umotoy, Xueyong Zhu

Plant Biotechnol J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
María Ríos Carrasco, Ting-Hui Lin, Xueyong Zhu, Alba Gabarroca García, Elif Uslu

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors.
Ting-Hui Lin, Xueyong Zhu, Shengyang Wang, Ding Zhang, Ryan McBride

Science· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4.
Meng Yuan, Linghang Peng, Deli Huang, Amanda Gavin, Fangkun Luan, Xueyong Zhu

Structure· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Xueyong Zhu

Proc Natl Acad Sci U S A· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site.
Andrew J Thompson, Nicholas C Wu, Angeles Canales, Chika Kikuchi, Xueyong Zhu

Cell Host Microbe· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4.
Meng Yuan, Linghang Peng, Deli Huang, Amanda Gavin, Fangkun Luan, Xueyong Zhu

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice.
Eduard Puente-Massaguer, Kirill Vasilev, Annika Beyer, Madhumathi Loganathan, Benjamin Francis, Xueyong Zhu

Sci Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Lena Hansen, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Jackson S Turner

Immunity· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.
Fangzhu Zhao, Meng Yuan, Celina Keating, Namir Shaabani, Oliver Limbo, Xueyong Zhu

Sci Signal· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Laetitia Misson Mindrebo, Hejun Liu, Gabriel Ozorowski, Quoc Tran, Jordan Woehl, Fangzhu Zhao, Xueyong Zhu

Proc Natl Acad Sci U S A· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.
Yupeng Feng, Meng Yuan, John M Powers, Mengyun Hu, Jennifer E Munt, Xueyong Zhu

Sci Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Xue-Yong Zhu, Xue-Hai Zhu

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift.
Ge Song, Meng Yuan, Hejun Liu, Tazio Capozzola, Ryan N Lin, Xueyong Zhu

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease.
Panpan Zhou, Ge Song, Hejun Liu, Meng Yuan, Wan-Ting He, Xueyong Zhu

Immunity· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.
Daniel Stadlbauer, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Hongquan Wan

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis